Almirall and Evotec to collaborate on multiple severe skin disease targets

A new dermatological alliance between Spanish skin health firm Almirall and German-listed Evotec aims to discover new drugs for the treatment of skin diseases including cancers and eczema.
Photo: Almirall / PR
Photo: Almirall / PR
by andreas lønstrup, translated by daniel pedersen

A new dermatological multi-target alliance was established on Thursday, as Almirall and Evotec join forces to discover new treatments for a variety of skin diseases, Almirall has announced in a press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading